A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies

BACKGROUND: The higher recurrence rate of hepatocellular carcinoma (HCC) needs to be urgently controlled. However, definitive markers are lacking for patients with recurrence of HCC after undergoing minimal invasive therapies—local ablation combined with transcatheter arterial chemoembolization (TAC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Manag Res
Autors principals: Wang, Qi, Ma, Liang, Li, Jianjun, Yuan, Chunwang, Sun, Jianping, Li, Kang, Qin, Ling, Zang, Chaoran, Zhao, Yanan, Zhao, Yan, Zhang, Yonghong
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930388/
https://ncbi.nlm.nih.gov/pubmed/31908536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S224711
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars